Growth hormone therapy in patients with Noonan syndrome
Noonan syndrome (NS) is an autosomal dominant disorder that involves multiple organ systems, with short stature as the most common presentation (>70%). Possible mechanisms of short stature in NS include growth hormone (GH) deficiency, neurosecretory dysfunction, and GH resistance. Accordingly, GH...
Saved in:
Main Authors: | Go Hun Seo (Author), Han-Wook Yoo (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Endocrinology,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome
by: Kyo Jin Jo, et al.
Published: (2019) -
Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
by: Insook Jeong, et al.
Published: (2016) -
Effectiveness of growth hormone therapy in children with Noonan syndrome
by: Eun mi Seok, et al.
Published: (2020) -
Correlation between genetic heterogeneity and variability for response to growth hormone in Noonan syndrome
by: Young-Lim Shin
Published: (2019) -
The Effect of Growth Hormone Therapy on Cardiac Outcomes in Noonan Syndrome: Long Term Follow-up Results
by: Sirmen Kızılcan Çetin, et al.
Published: (2022)